Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis

Launched by CHU DE REIMS · Dec 18, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a treatment for adhesive capsulitis, a condition that causes pain and limits movement in the shoulder. The researchers want to see if adding a specific type of pain relief called a suprascapular nerve block to standard treatments can help patients recover faster and improve their shoulder function compared to just using the usual methods. The trial is looking for participants who are at least 18 years old and have significant shoulder stiffness, as indicated by a loss of movement in their shoulder compared to the other side.

If you decide to participate, you will receive either the nerve block along with conventional therapy or just the conventional therapy alone. You’ll be monitored for improvements in your shoulder pain and mobility over one month. It's important to note that certain individuals, such as pregnant women or those who have had recent shoulder surgery, cannot join the study. This trial could offer a potential new way to help people with adhesive capsulitis feel better and regain their shoulder movement more quickly.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient treated for adhesive capsulitis corresponding to a loss of passive amplitude of more than 20° in external rotation elbow to body and/or abduction in relation to the contralateral shoulder.
• • Patient over 18 years of age
• • Patient covered by a social security scheme
• • Presence of an accompanying person on the day of the procedure for the return trip
• • Patient having signed the consent form to participate in the study
• Exclusion Criteria:
• • Patient protected by law
• • Pregnant women
• • Patient who has had shoulder surgery less than six months old
• • Patient unable to undergo rehabilitation within one month of surgery
• • Allergy to one of the products used (anesthetic, iodinated contrast medium)
• • Neuro-orthopedic disorder hampering clinical recovery
• • Hemostasis disorder contraindicating block (no discontinuation of anticoagulants according to SFAR recommendations, congenital hemostasis disorder)